Fenofibrate in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

March 4, 2020

Study Completion Date

March 4, 2020

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Fenofibrate

40 patients (20 males and 20 females) aged 18-70 years, with type 2 diabetes and triglycerides \>150 mg/dL will be recruited. They will have a physical exam and blood draw at visit 1. Participants will receive 160 mg fenofibrate to be taken orally daily for six weeks. They will return for a second visit after 6 weeks and have blood draw as follow up.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03829514 - Fenofibrate in Type 2 Diabetes | Biotech Hunter | Biotech Hunter